What’s the “gold standard” to determine what is a true case?
It depends on the condition in question, but for a viral RT-PCR a range of concentrations of RNA or virus can be added to a negative sample to help determine the limit of detection
2/n
Specificity = proportion of unaffected ppl that a test correctly identifies as not having the disease
99% specific means 99 out of 100 truly unaffected ppl will be correctly labelled as being negative.
Many known negative samples will be examined to determine this value.
3/n
But it’s extremely important to consider the test in the context of what’s called the “pre-test probability”
4/n
This takes a second to think through, but the more common a disease is in a population, the more likely you are to actually have the condition if given a positive result.
5/n
Bayes's theorem
the probability you test positive AND are sick is the product of the likelihood that you test positive GIVEN that you are sick and the "prior" probability that you are sick (the prevalence in the population).
6/n
This is a really interesting point. Is a less sensitive test (or less specific) better is it’s more available?
It very much depends, in my opinion, on the consequences of an error. A readily available but insensitive test is inadequate if it puts vulnerable ppl at risk.
If it’s used to assess changes in the population at large, well then it’s less of a problem.this could still be very useful to guide policy decisions.
8/n
The trade-offs between sensitivity / specificity are therefore complex & often subtle. Maybe Twitter isn’t the ideal medium for this discussion, but it’s better than no discussion at all.
Testing is, however, key to controlling this pandemic.
9/9
*by “this” I mean David’s comment, not Bayes’ theorem, which is also very interesting but not related to the question of test availability*
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The new “Kent” strain of SARS-CoV-2 (officially named VUI 202012/01 for Variant Under Investigation, year 2020, month 12, variant 01) was identified as have multiple spike protein mutations
1/n
These include deletion 69-70, deletion 144-145, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H
1860s: nucleic acids discovered
1940-50s: the concept that “DNA makes RNA makes protein” is developed (& is called the central dogma)
1960s: messenger RNA discovered
1/n
Path to the vaccine
1989: use of lipid nanoparticles to get mRNA into cells
1990: RNA injected into muscle can cause local synthesis of a protein
1994-9: RNA vaccines shown to induce immune response
2008-11: early phase trials
2/n
2003-2012: studies to generate a vaccine against 2 new severe coronavirus diseases SARS and MERS identify the spike protein as a good target for protective antibodies
3/n
Observations are made.
A hypothesis is generated.
Experiments are performed to test (try to disprove) the hypothesis.
This cycle is repeated many many times until the experiments are unable to disprove the hypothesis.
The results are shared at talks or posters at conferences or as preprints, so others can comment & criticise.
The results are then published as papers (a gruelling process when the paper is assessed by tough anonymous scientists who point out every error, big or small, which must be corrected).
Afterwards, scientists try to reproduce those results to see if they’re real.